GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Wu, Meei Maan ^a,b,c   Chiou, Hung Yi ^a   Lee, Te Chang ^d   Chen, Chi Ling ^b   Hsu, Ling I ^e   Wang, Yuan Hung ^a   Huang, Wen Ling ^a   Hsieh, Yi Chen ^a   Yang, Tse Yen ^e   Lee, Cheng Yeh ^e   Yip, Ping Keung ^f   Wang, Chih Hao ^c   Hsueh, Yu Mei ^a   Chen, Chien Jen ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; HEME OXYGENASE 1;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; DOPPLER ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE; RISK FACTOR; TAIWAN; CAROTID ARTERY DISEASE; CHEMICALLY INDUCED DISORDER; DINUCLEOTIDE REPEAT; ECHOGRAPHY; GENE FREQUENCY; GENETICS; RISK; STATISTICAL MODEL; WATER POLLUTANT;

ARSENIC; CAROTID ARTERY DISEASES; DINUCLEOTIDE REPEATS; GENE FREQUENCY; HEME OXYGENASE-1; HUMANS; LOGISTIC MODELS; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TAIWAN; WATER POLLUTANTS, CHEMICAL;

EID: 77955951478     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-70     Document Type: Article

References (38)

1. Arsenic in drinking water. 2001 update. National Research Council, Washington, DC 2001
2. Arsenic and arsenic compounds. World Health Organization, Geneva: World Health Organization 2001
3. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. A Navas-Acien AR Sharrett EK Silbergeld BS Schwartz KE Nachman TA Burke E Guallar, Am J Epidemiol 2005 162 11 1037 1049 10.1093/aje/kwi330 16269585
4. Arsenic and cardiovascular disease. JC States S Srivastava Y Chen A Barchowsky, Toxicol Sci 2009 107 2 312 323 10.1093/toxsci/kfn236 19015167
5. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in TWN. CH Tseng, Atherosclerosis 2008 199 1 12 18 10.1016/j.atherosclerosis.2008.02.013 18367191
6. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. CH Wang JS Jeng PK Yip CL Chen LI Hsu YM Hsueh HY Chiou MM Wu CJ Chen, Circulation 2002 105 15 1804 1809 10.1161/01.CIR.0000015862.64816.B2 11956123
7. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. CJ Chen HY Chiou MH Chiang LJ Lin TY Tai, Arterioscler Thromb Vasc Biol 1996 16 4 504 510 8624771
8. Effects and dose - response relationships of skin cancer and blackfoot disease with arsenic. WP Tseng, Environ Health Perspect 1977 19 109 119 10.2307/3428460 908285
9. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. A Hernandez R Marcos, Pharmacogenomics 2008 9 8 1113 1132 10.2217/14622416.9.8.1113 18681785
10. Inflammation and atherosclerosis. P Libby PM Ridker A Maseri, Circulation 2002 105 9 1135 1143 10.1161/hc0902.104353 11877368
11. Heme oxygenase and atherosclerosis. T Morita, Arterioscler Thromb Vasc Biol 2005 25 9 1786 1795 10.1161/01.ATV.0000178169.95781.49 16020746
12. Hemoxygenase-1 in cardiovascular disease. NK Idriss AD Blann GY Lip, J Am Coll Cardiol 2008 52 12 971 978 10.1016/j.jacc.2008.06.019 18786476
13. Pharmacological and clinical aspects of heme oxygenase. NG Abraham A Kappas, Pharmacol Rev 2008 60 1 79 127 10.1124/pr.107.07104 18323402
14. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Y Lavrovsky ML Schwartzman RD Levere A Kappas NG Abraham, Proc Natl Acad Sci USA 1994 91 13 5987 5991 10.1073/pnas.91.13.5987 8016102
15. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. YH Chen SJ Lin MW Lin HL Tsai SS Kuo JW Chen MJ Charng TC Wu LC Chen YA Ding WH Pan YS Jou LY Chau, Hum Genet 2002 111 1 1 8 10.1007/s00439-002-0769- 4 12136229
16. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. N Yamada M Yamaya S Okinaga K Nakayama K Sekizawa S Shibahara H Sasaki, Am J Hum Genet 2000 66 1 187 195 10.1086/302729 10631150
17. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. P Dick M Schillinger E Minar W Mlekusch J Amighi S Sabeti O Schlager M Raith G Endler C Mannhalter O Wagner M Exner, Eur J Clin Invest 2005 35 12 731 737 10.1111/j.1365-2362.2005.01580.x 16313248 (Pubitemid 41783589)
18. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. H Kaneda M Ohno J Taguchi M Togo H Hashimoto K Ogasawara T Aizawa N Ishizaka R Nagai, Arterioscler Thromb Vasc Biol 2002 22 10 1680 1685 10.1161/01.ATV.0000033515. 96747.6F 12377749
19. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. M Schillinger M Exner E Minar W Mlekusch M Mullner C Mannhalter FH Bach O Wagner, J Am Coll Cardiol 2004 43 6 950 957 10.1016/j.jacc.2003.09.058 15028349
20. Stress proteins induced by arsenic. LM Del Razo B Quintanilla-Vega E Brambila-Colombres ES Calderon-Aranda M Manno A Albores, Toxicol Appl Pharmacol 2001 177 2 132 148 10.1006/taap.2001.9291 11740912
21. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. MM Wu HY Chiou IC Ho CJ Chen TC Lee, Environ Health Perspect 2003 111 11 1429 1438 12928151
22. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. CJ Chen CJ Wang, Cancer Res 1990 50 17 5470 5474 2386951
23. Increased prevalence of hypertension and long-term arsenic exposure. CJ Chen YM Hsueh MS Lai MP Shyu SY Chen MM Wu TL Kuo TY Tai, Hypertension 1995 25 1 53 60 7843753
24. Ingested inorganic arsenic and prevalence of diabetes mellitus. MS Lai YM Hsueh CJ Chen MP Shyu SY Chen TL Kuo MM Wu TY Tai, Am J Epidemiol 1994 139 5 484 492 8154472
25. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in TWN. YH Wang MM Wu CT Hong LM Lien YC Hsieh HP Tseng SF Chang CL Su HY Chiou CJ Chen, Atherosclerosis 2007 192 2 305 312 10.1016/j.atherosclerosis.2006.07.029 16973168
26. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. MM Wu HY Chiou YM Hsueh CT Hong CL Su SF Chang WL Huang HT Wang YH Wang YC Hsieh CJ Chen, Toxicol Appl Pharmacol 2006 216 1 168 175 10.1016/j.taap.2006.05.005 16806340
27. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. HY Chiou WI Huang CL Su SF Chang YH Hsu CJ Chen, Stroke 1997 28 9 1717 1723 9303014
28. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Report. TL Kuo, Instiitute of Pathology, National TWN University 1964 60 1139 1140
29. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in TWN. CL Chen LI Hsu HY Chiou YM Hsueh SY Chen MM Wu CJ Chen, Jama 2004 292 24 2984 2990 10.1001/jama.292.24.2984 15613666
30. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in TWN. HY Chiou YM Hsueh KF Liaw SF Horng MH Chiang YS Pu JS Lin CH Huang CJ Chen, Cancer Res 1995 55 6 1296 1300 7882325
31. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. T Kimpara A Takeda K Watanabe Y Itoyama S Ikawa M Watanabe H Arai H Sasaki S Higuchi N Okita S Takase H Saito K Takahashi S Shibahara, Hum Genet 1997 100 1 145 147 10.1007/s004390050480 9225984
32. Methods for precise sizing, automated binning of alleles, and reduction of error rates in large-scale genotyping using fluorescently labeled dinucleotide markers. FUSION (Finland-U.S. Investigation of NIDDM Genetics) Study Group. S Ghosh ZE Karanjawala ER Hauser D Ally JI Knapp JB Rayman A Musick J Tannenbaum C Te S Shapiro W Eldridge T Musick C Martin JR Smith JD Carpten MJ Brownstein JI Powell R Whiten P Chines SJ Nylund VL Magnuson M Boehnke FSl Collins, Genome Res 1997 7 2 165 178 10.1101/gr.7.2.165 9049634
33. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern TWN. MM Wu HY Chiou TW Wang YM Hsueh IH Wang CJ Chen TC Lee, Environ Health Perspect 2001 109 10 1011 1017 10.2307/3454955 11675266
34. Multiple basic-leucine zipper proteins regulate induction of the mouse heme oxygenase-1 gene by arsenite. P Gong D Stewart B Hu C Vinson J Alam, Arch Biochem Biophys 2002 405 2 265 274 10.1016/S0003-9861(02)00404-6 12220541
35. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. KK Elbirt AJ Whitmarsh RJ Davis HL Bonkovsky, J Biol Chem 1998 273 15 8922 8931 10.1074/jbc.273.15.8922 9535875
36. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. T Miralem Z Hu MD Torno KM Lelli MD Maines, J Biol Chem 2005 280 17 17084 17092 10.1074/jbc.M413121200 15741166
37. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. PC Lee IC Ho TC Lee, Toxicol Sci 2005 85 1 541 550 10.1093/toxsci/kfi101 15689417
38. Induction of heme oxygenase-1 inhibits monocyte chemoattractant protein-1 mRNA expression in U937 cells. T Shokawa M Yoshizumi H Yamamoto S Omura M Toyofuku Y Shimizu M Imazu N Kohno, J Pharmacol Sci 2006 100 2 162 166 10.1254/jphs.SC0040188 16474202